Newsblaster Archived Run
Click here to return to today's news.
Friday, June 13, 2008
Articles from 06/10/2008 to 06/13/2008
Last update: 4:34 AM EST
Search for:
U.S.
World
Finance
Sci/Tech
Entertainment
Sports

View Today's Images

Back to Archive Index

About Newsblaster

About today's run

Newsblaster in Press

Academic Papers

Article Sources:
washingtonpost.com
(316 articles)
news.bbc.co.uk
(157 articles)
nytimes.com
(143 articles)
cbc.ca
(135 articles)
boston.com
(94 articles)
baltimoresun.com
(70 articles)
dallasnews.com
(67 articles)
ft.com
(64 articles)
abcnews.go.com
(62 articles)
suntimes.com
(53 articles)
latimes.com
(51 articles)
foxnews.com
(45 articles)
timesonline.co.uk
(35 articles)
nypost.com
(32 articles)
cnn.com
(15 articles)
money.cnn.com
(10 articles)
wired.com
(10 articles)
cbsnews.com
(9 articles)
business.
timesonline.co.uk

(8 articles)
technology.
timesonline.co.uk

(7 articles)
sfgate.com
(5 articles)
thecaucus.
blogs.nytimes.com

(5 articles)
msnbc.msn.com
(5 articles)
bits.
blogs.nytimes.com

(4 articles)
politics.
nytimes.com

(4 articles)
nature.com
(3 articles)
cowboysblog.
dallasnews.com

(2 articles)
zdnet.com
(2 articles)
lakersblog.
latimes.com

(2 articles)
property.
timesonline.co.uk

(2 articles)
usatoday.com
(2 articles)
weblogs.
baltimoresun.com

(1 article)








Raloxifene Cuts Risk of Certain Type of Breast Cancer
Summary from multiple countries, from articles in English
Teenagers may be more susceptible than adults to certain types of cancer, including cervical, testicular and skin cancer, British scientists said this week. (article 5) Certain cancer rates rose faster among adolescents in England than in adults from 1979 to 2003, according to research presented at an international conference on teenage cancer in London. (article 4) A new analysis finds that those who took raloxifene (Evista) regularly over a number of years were less likely to develop invasive estrogen-receptor (ER) positive breast cancer, compared with women who did not take the drug. (article 9) A sweeping study on how genetics, environmental factors and lifestyle choices play a part in the development of cancer was launched Wednesday. (article 3) The study of 300,000 Canadians will take place over the next 20 to 30 years and gather information on cancer risk factors through surveys and blood collection. (article 3) On average, breast cancer was identified when it was present (sensitivity) in 79.6 percent of breast cancer cases that occurred within one year. (article 8) The upward trend, seen with breast, lung and colorectal cancer in particular, reflects the fact that more patients are receiving radiation and chemotherapy, and those treatments are costing more. (article 1)

Other summaries about this story:
  • Summary from United States, from articles in English (7 articles) [compare]
  • Summary from the United Kingdom, from articles in English (2 articles) [compare]
  • Summary from Canada, from articles in English (2 articles) [compare]

  • Event tracking:
  • Track this story's development in time

  • Story keywords
    cancer, breast, Raloxifene, colorectal, patients

    Source articles
    1. Medicare Costs for Cancer Treatment Soar (Washington Post, 06/10/2008, 777 words)
    2. Graveyard Shift Work Linked to Cancer (Washington Post, 06/12/2008, 328 words)
    3. Cancer risk factors to be studied in large-scale study (cbc.ca, 06/11/2008, 286 words)
    4. Teens may be more susceptible to some cancers (Washington Post, 06/12/2008, 454 words)
    5. Cancer rates rise faster for teens than adults, scientists find - (baltimoresun.com, 06/13/2008, 164 words)
    6. Cancer treatment waiting time cut (BBC News, 06/10/2008, 233 words)
    7. Africa's looming cancer epidemic (BBC News, 06/12/2008, 908 words)
    8. Facility Characteristics Influence Mammography Accuracy (Washington Post, 06/11/2008, 348 words)
    9. Raloxifene Cuts Risk of Certain Type of Breast Cancer (Washington Post, 06/11/2008, 528 words)
    10. DNA Coding May Make Bowel Prone to Cancer (Washington Post, 06/11/2008, 358 words)
    11. Colorectal cancer screening research trial approved in Sask. (cbc.ca, 06/12/2008, 357 words)




    blaster@cs.columbia.edu